XENE shares gain 20% in 3 months as positive phase III data for epilepsy drug azetukalner and pipeline progress boost outlook and investor confidence.

Research identifies a gene that may be linked to focal cortical dysplasia, a common cause of drug-resistant epilepsy. New research has identified changes (mutations) in a gene called FOXJ3 that may be ...

Epilepsy is one of the common disorders known to man, with early accounts of the disorder traced back to antiquity.1 It was ...

Objective: The aim was to study the epidemiological aspects of febrile seizures and to identify etiologies in children from 1 ...

Discover how ultra-early epilepsy surgeries transform the lives of children with drug-resistant seizures, preventing long-term brain damage.

People often associate seizures and major neurological problems that have convulsions or loss of consciousness. Remember, a brief blank stare, a curious sense of déjà vu, a few seconds of unexplained ...

Seizures are more common than many people may think. Here are some simple steps you can take to protect a person having a ...

X-TOLE2 met primary endpoint in both dose groups, including -53.2% median percent change (MPC) from baseline in monthly FOS frequency with 25 mg dose compared with -10.4% for placebo (p=0.000000000006 ...

A recent integrative analysis of single-cell sequencing and single-cell spatial mapping of lymph node metastasis in breast cancer reveals novel mechanisms of the metabolic-immune interaction that ...

Many families face the challenge of drug-resistant epilepsy, questioning the transition from medication to surgery.

Researchers are optimistic after early results showed that experimental drug treatment zorevunersen may significantly reduce the number of seizures in children with a rare and severe form of epilepsy.

DelveInsight forecasts a rise in the drug-resistant epilepsy market from 2025 to 2034, driven by higher prevalence, improved diagnosis, treatment advances, aging demographics, increased awareness, and ...